Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Morton Sosland Insider Profile
4 Followers
Morton Sosland, Ten Percent Owner at Intra-Cellular Therapies, holds 3.64M shares in Intra-Cellular Therapies (Ticker: ITCI). Most recently, Morton Sosland Bought $250,000 shares of Intra-Cellular Therapies on Mar 12, 2015 for an estimated value of 6.00M.
Morton Sosland has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Ten Percent Owner
Roles that Morton Sosland holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 12, 2015 - Mar 12, 2016
Return:+19.30%
The most profitable trade made by Morton Sosland
Morton Sosland's Trading History
List of latest transactions for each holding click on a transaction to see Morton Sosland's performance on stock
You May Also Like
Morton Sosland insider profile FAQ
What is the percentage of profitable transactions made by Morton Sosland?
The percentage of profitable transactions made by Morton Sosland is ―.
What is the average return per transaction made by Morton Sosland?
The average return per transaction made by Morton Sosland is ―.
What stocks does Morton Sosland hold?
Morton Sosland holds: ITCI stocks.
What was Morton Sosland’s latest transaction?
Morton Sosland latest transaction was an Informative Buy of $6.00M.
What was Morton Sosland's most profitable transaction?
Morton Sosland’s most profitable transaction was an Informative Buy of ITCI stock on March 12, 2015. The return on the trade was 19.30%.
What is Morton Sosland's role in Intra-Cellular Therapies?
Morton Sosland's role in Intra-Cellular Therapies is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.